As a Coordinator at the International Unit of the Health Intervention and Technology Assessment Program (HITAP), Piyaphat supports regional and global initiatives that strengthen health systems through evidence-informed policymaking. With a background in liberal arts and professional experience across the humanitarian, public, and private sectors,

A new oral medication to treat patients in the early stages of multiple sclerosis has shown considerable promise in two clinical trials, researchers announced on Wednesday.The medication is on track to become just the third oral drug available to M.S. patients, and potentially the safest and most ef

HTAsiaLink 20188-11 May 2018, Chiang Mai, ThailandMore than 200 participants from over 30  HTA organizations and other academic and policy making agencies across the global joined this conference!The themes of this years’ conference is Testing Treatments: Strengthening HTA for better healthcare.For

Phornnaphat is a licensed pharmacist with a diverse academic background, holding a bachelor\'s degree in pharmacy from Silpakorn University and a master’s degree in molecular biology from Nagoya University (MEXT Scholarship). With this interdisciplinary training, she specializes in applying data and evidence to inform health policy.Her research foc

In early 2019, the Philippines passed a Universal Health Coverage (UHC) Act that automatically enrolls all Filipino citizens in a national health insurance scheme under the Philippine Health Insurance Corporation (PhilHealth). P0F0F1 P Their aim, to improve the breadth and depth of healthcare cove

The license termination, which concerns three clinical-stage products using Acura’s Aversion technology, will be effective a year from Thursday, when Pfizer notified the company.“We will evaluate our strategy for these products (being returned) over the coming months, including possible partnering w

The settlement is part of a broad crackdown on bribery by multinational companies in foreign countries that has hit several of the world’s biggest pharmaceutical companies.Pfizer in 2004 became the first pharmaceutical company to volunteer information about past wrongdoing to the Justice Department,

Investors cheered the news, sending shares of the drugmaker soaring 50 percent to $4.59 on the Nasdaq on Friday afternoon.The Phase 2 trial, involving 121 previously treated non-small cell lung cancer patients, found that those given a lower dose of bavituximab plus chemotherapy lived for a median o

ROONGNAPA KHAMPANG1,2, SAWITRI ASSANANGKORNCHAI1 & YOT TEERAWATTANANON2 1Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, HatYai, Songkhla, Thailand, and 2Health Intervention and Technology Assessment Program, Department of Health, Ministry of Public Health, Nonthaburi, Tha

Abstract Introduction. Many countries have introduced pay-for-performance (P4P) models to encourage health providers and institutions to provide good quality of care. In 2013, the National Health Security Office of Thailand introduced P4P, based on the UK Quality and Outcomes Framework (QOF),